EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications

Marco Oderda, Romain Diamand, Rawad Abou Zahr, Julien Anract, Gregoire Assenmacher, Nicolas Barry Delongchamps, Alexandre Patrick Bui, Daniel Benamran, Giorgio Calleris, Charles Dariane, Mariaconsiglia Ferriero, Gaelle Fiard und 12 weitere

World Journal of Urology · 2024

DOI: 10.1007/s00345-024-05245-1 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift World Journal of Urology, 2024. Verfasst von Marco Oderda und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgical Sciences, Molinette Hospital, University of Turin, Turin, Italy. marco.oderda@unito.it. Hauptthemen laut MEDLINE: Image-Guided Biopsy, Prostatic Neoplasms, Prostate. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Torino.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate biopsy-related complications and detection rates of any PCa and clinically significant PCa (csPCa, intended as grade group ≥ 2) between MRI-targeted TP fusion biopsies (TPBx) and TR ones (TRBx).

Methods

We performed a multicentric study on 4841 patients who underwent fusion biopsy between 2016 and 2023. A case–control matching was performed to find comparable cohorts of 646 TPBx and 646 TRBx. Mean T test and Pearson chi-square tests were used to compare continuous and categorical variables.

Results

Baseline characteristics were comparable between the cohorts, except for target location with a higher rate of anterior lesions in TPBx group. Complications were rare and no difference was found between the groups, with similar rates of infections after TRBx and TPBx (N = 5 (0.8%) vs N = 2 (0.3%), p 0.45). All patients in TRBx and 90.1% in TPBx group received antibiotic prophylaxis. A higher csPCa detection rate was found in TPBx over the group (50.5% vs 36.2%, p < 0.001). On average, positive targeted cores were increased in TPBx group, for any PCa (1.6 vs 1.4, p 0.04) and csPCa (1.0 vs 0.8, p 0.02). Among the limitations of study, we acknowledge the retrospective design and the possible under-reporting of complications.

Conclusions

MRI-targeted fusion TPBx achieves a significantly higher csPCa detection than TRBx, with a diagnostic advantage for apical and anterior lesions. No significant differences were found in terms of complications that were rare in both groups, considering a widespread adoption of antibiotic prophylaxis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Image-Guided BiopsyProstatic NeoplasmsProstateHumansMaleMiddle AgedAgedRetrospective StudiesPerineumRectumMatched-Pair AnalysisCase-Control StudiesPostoperative ComplicationsMagnetic Resonance ImagingReproducibility of Results

Stichwörter der Autor:innen

AccuracyComparisonComplicationsFusionProstate biopsyTransperinealTransrectal

Autor:innen und Institutionen

  • Division of Urology, Department of Surgical Sciences, Molinette Hospital, University of Turin, Turin, Italy. marco.oderda@unito.it.
  • Department of Urology, Jules Bordet Institute-Erasme Hospital, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
  • Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Division of Urology, Cochin Hospital, APHP, Paris Cité University, Paris, France.
  • Department of Urology, Cliniques de L'Europe-Saint Elisabeth, Brussels, Belgium.
  • Department of Urology, Centre Hospitalier Universitaire de Reims, Reims, France.

Förderung

  • Università degli Studi di Torino

Zitieren

APA

Oderda, M., Diamand, R., Abou Zahr, R., Anract, J., Assenmacher, G., Barry Delongchamps, N., Bui, A. P., Benamran, D., Calleris, G., Dariane, C., Ferriero, M., Fiard, G., Taha, F., Fourcade, A., Fournier, G., Guenzel, K., Halinski, A., Marra, G., Ploussard, G., …, & Gontero, P. (2024). Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications. World Journal of Urology. https://doi.org/10.1007/s00345-024-05245-1

Vancouver

Oderda M, Diamand R, Abou Zahr R, Anract J, Assenmacher G, Barry Delongchamps N, et al. Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications. World Journal of Urology. 2024. doi:10.1007/s00345-024-05245-1

BibTeX
@article{Oderda2024,
  author = {Oderda, Marco and Diamand, Romain and Abou Zahr, Rawad and Anract, Julien and Assenmacher, Gregoire and Barry Delongchamps, Nicolas and Bui, Alexandre Patrick and Benamran, Daniel and Calleris, Giorgio and Dariane, Charles and Ferriero, Mariaconsiglia and Fiard, Gaelle and Taha, Fayek and Fourcade, Alexandre and Fournier, Georges and Guenzel, Karsten and Halinski, Adam and Marra, Giancarlo and Ploussard, Guillaume and Rysankova, Katerina and Roche, Jean-Baptiste and Simone, Giuseppe and Windisch, Olivier and Gontero, Paolo},
  title = {Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications},
  journal = {World Journal of Urology},
  year = {2024},
  doi = {10.1007/s00345-024-05245-1}
}
Kostenlos starten →